The recommendations include internationally accepted definitions of terminology, greater transparency with the public, and stronger biorisk-management systems and oversight.
The NSABB endorses findings from two of its working groups, one on oversight of potential pandemic pathogens and the other on dual-use research of concern.
Draft recommendations from a panel that advises the NIH would tighten oversight of potentially dangerous pathogens.
Work on a hybrid SARS-CoV-2 virus has inflamed more controversy about lab biosafety and federal oversight
Biopharmaceutical company Spero Therapeutics announced today that it has entered into a licensing agreement with GSK for the antibiotic tebipenem pivoxil hydrobromide (HBr).
The World Health Organization (WHO) today announced the release of the first global framework on the responsible use of life sciences, which addresses the accidental or deliberate misuse of biologic and other life sciences, including dual-use research.
A retrospective study of 17 COVID-19 survivors with lingering symptoms reveals that 10 (59%) had nerve damage, which the researchers said could have been triggered by potentially treatable infection-related immune dysfunction.
In an ongoing surge of MERS-CoV activity, Saudi Arabia's health ministry today announced nine new cases, including seven that are possibly linked to a hospital outbreak in Wadi ad-Dawasir, according to an update to its epidemiological week 7 report.
Re-creating known pathogenic viruses and making existing bacteria more dangerous are among the top threats.
Researchers are relieved to resume experiments, but some public health questions remain.
